Greater competition is the answer, Mr. Merritt said, and he praised recent efforts by the Food and Drug Administration
According to University of Chicago economics professor Casey Mulligan, pharmacy benefit companies provide many services to participants across the healthcare system. The value to society of all of these services is a whopping $145 billion. Every. Single. Year. What would happen to
Pharmacy benefit companies play an important and unique role in the drug supply and payment chain. Employers, labor unions, health plans, government agencies, drug companies, pharmacies, and most importantly patients all benefit from pharmacy benefit company services.
I have been the Head of the Research Team at PCMA, representing the pharmacy benefit industry, for nearly four years. And while it is part of my job to research and write about the clinical care activities of pharmacy benefit
Given this growing challenge, pharmacy benefit managers (PBMs) have never been more essential. For both public programs and private insurance, PBMs are actively engaged in keeping prescription drug costs down and making medications more affordable for individual patients.
The drug giants moved in near-perfect synchronicity, raising prices for their top-selling arthritis treatments as though they were opposite-corner gas stations bumping up the price of unleaded.
FDA Commissioner Scott Gottlieb calls “patent thickets,” claiming multiple patents for a single drug to build protection from competitors.
©2024 PCMA. All Rights Reserved.
